Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02082912 · ClinicalTrials.gov registry record · Phase 2
NMDA Receptors in Motor Learning in Humans
A Phase 2 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
NCT02082912 is a Phase 2 study that has completed, run by Emory University. The registered enrollment target is 14 participants.
The verdict
NCT02082912, a Phase 2 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to focus on enhancing upper limb recovery in patients post-stroke by using robotic-assisted therapy in combination with a drug to improve learning new motor skills.
Interventions
- OTHER Placebo
- DRUG D-cycloserine
- DEVICE HandMentor Pro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02082912
The ClinicalTrials.gov registry entry for NCT02082912 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02082912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02082912 about?
NCT02082912 is a clinical study titled "NMDA Receptors in Motor Learning in Humans". The purpose of this study is to focus on enhancing upper limb recovery in patients post-stroke by using robotic-assisted therapy in combination with a drug to improve learning new motor skills.
What is the current status of trial NCT02082912?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2010-06. Estimated completion is 2012-04.
What interventions are being tested in trial NCT02082912?
The interventions under investigation include: Placebo (OTHER), D-cycloserine (DRUG), HandMentor Pro (DEVICE).
Who is sponsoring clinical trial NCT02082912?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.